David C. Hanley
Chief Technical Operations OfficerDr. David C. Hanley, Ph.D., serves as Chief Technical Operations Officer of Nuvation Bio Inc. since June 2021. Prior to this role, from August 2018 to May 2021, Dr. Hanley held positions of increasing responsibility at BioXcel Therapeutics Inc., most recently serving as Senior Vice President and Head of Global Pharmaceutical Development and Operations. Dr. Hanley is experienced in Chemistry, Manufacturing and Controls (CMC) and Technical Operations functions and cross-functional development teams in the U.S. and Europe. From August 2014 to August 2018, Dr. Hanley held positions of increasing responsibility at Radius Health, Inc., most recently serving as Vice President of Pharmaceutical Sciences and Technical Operations. He also held positions at The Medicines Company from June 2011 to August 2014, including Senior Director. Prior to that, Dr. Hanley held positions at Boehringer Ingelheim from August 2010 to December 2010, The Medicines Company from September 2009 to July 2010, Medarex Inc. from September 2006 to September 2009, and Berlex, a subsidiary of Schering A.G., from November 2001 to September 2006. He has authored multiple peer-reviewed publications, conference presentations, and patents. Dr. Hanley received his B.S. in chemistry from Virginia Commonwealth University. He earned Ph.D. in physical and analytical chemistry from University of Utah.
Positions
- Company NameNuvation Bio Inc.Stock CodeNUVBPositionChief Technical Operations OfficerColleagues
- DTDavid T. HungFounder, President, CEO & Chairman
- PPPhilippe Pierre SauvageCFO & Principal Financial Officer
- GHGary HattersleyChief Scientific Officer
- MMMoses MakunjeVP of Finance and Principal Accounting & Financial Officer
- WAWilliam Anthony VernonIndependent Director
- RBRobert B. BazemoreLead Independent Director
- KEKathryn E. FalbergIndependent Director
- KDKim D. BlickenstaffIndependent Director
